Geneva — A push to increase production of Covid-19 vaccines for poor nations hung in the balance at the World Trade Organization on Wednesday amid disagreement between richer and developing countries over the issue of patent rights.

SA and India planned to renew their bid at a two-day meeting to waive rules of the WTO’s Trade-Related Aspects of Intellectual Property Rights (Trips) agreement, a move that would allow generic or other manufacturers to make more vaccines...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.